Methyl 2-(bis(tert-butoxycarbonyl)amino)-5-bromothiophene-3-carboxylate

Catalog No. :
ACURZB153
CAS No. :
2227990-15-8
Molecular Formula :
C16H22BrNO6S
Molecular Weight :
436.32

IUPAC Name:methyl 2-(bis(tert-butoxycarbonyl)amino)-5-bromothiophene-3-carboxylate

Methyl 2-(bis(tert-butoxycarbonyl)amino)-5-bromothiophene-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$95.00Login to see priceInquiryInquiry
1g95%$237.00Login to see priceInquiryInquiry
5g95%$647.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(bis(tert-butoxycarbonyl)amino)-5-bromothiophene-3-carboxylate
IUPAC Namemethyl 2-(bis(tert-butoxycarbonyl)amino)-5-bromothiophene-3-carboxylate
MDL No.MFCD31630366
Molecular FormulaC16H22BrNO6S
Molecular Weight436.32
SMILESO=C(C1=C(N(C(OC(C)(C)C)=O)C(OC(C)(C)C)=O)SC(Br)=C1)OC
InChI KeyHLTVNWZBFVNHMM-UHFFFAOYSA-N
Synonym3-Thiophenecarboxylic acid, 2-[bis[(1,1-dimethylethoxy)carbonyl]amino]-5-bromo-, methyl ester
CAS No.2227990-15-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACURZB153 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOULQ140 route compound structure diagram
    ACOULQ140859204-25-4 In Stock
  4. Then
  5. ACURZB153 route product structure diagram
    ACURZB1532227990-15-8
Inquiry

2. ACURZB153 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACURZB153 route product structure diagram
    ACURZB1532227990-15-8
Inquiry

Comments (0)